Tumor necrosis factor (TNF) is thought to be a key mediator of the inflammatory and fibrotic response to Chlamydia trachomatis (Ct) infection. A large matched-pair case-control study investigated putative functional single nucleotide polymorphisms (SNPs) across the major histocompatibility complex (MHC) class III region, including TNF and its immediate neighbors nuclear factor of k light polypeptide gene enhancer in B cells (IkBL), inhibitor like 1 and lymphotoxin alpha (LTA) in relation to the risk of scarring sequelae of ocular Ct infection. Haplotype and linkage disequilibrium analysis demonstrated two haplotypes, differing at position TNF-308, conferring an increased risk of trichiasis. The TNF-308A allele, and its bearing haplotype, correlated with increased TNF production in lymphocyte cultures stimulated with chlamydial elementary body antigen. Thus TNF-308A may determine directly, or be a marker of a high TNF producer phenotype associated with increased risk of sequelae of chlamydial infection. Multivariate analysis provided evidence for the presence of additional risk-associated variants near the TNF locus.
Introduction
Trachoma, caused by ocular Chlamydia trachomatis infection, is the world's leading infectious cause of blindness. Generally, the infection resolves without long-term complications, but a proportion of infected individuals develop a chronic inflammatory process that leads to conjunctival scarring (TS), distortion of the eyelids trichiasis (TT), corneal opacity and ultimately blindness. Genital C. trachomatis infection causes similar lesions in the female genital tract, leading to ectopic pregnancy and infertility. The mechanisms of immunity and pathogenesis are not clear.
Cytokines, especially tumor necrosis factor (TNF), may affect the outcome of trachoma, either by inducing the host response to suppress chlamydial infection, [1] [2] [3] or by mediating inflammatory and fibrotic changes in the conjunctiva involved in the pathogenesis of chlamydial disease. [4] [5] [6] [7] [8] Studies have suggested that local overproduction of TNF during chlamydial-induced ocular disease may have adverse consequences for the human host: increased TNF transcripts have been observed in the inflamed conjunctiva during active trachoma [8] [9] [10] and higher levels of TNF were found in the tear fluid of scarred individuals compared to matched controls with normal eyes. 4 In the latter study, genotyping of TNF promoter À308 and À238 SNPs showed that the TNFÀ308A allele was associated with risk of scarring trachoma. 4 The mechanism of this association, however, was not clear because the TNF levels in the tear fluid did not correlate with TNFÀ308 genotypes. This adds to the generally inconsistent epidemiological and functional reports of the TNFÀ308 SNP 11 and raise the possibility that the genetic association in trachoma may have derived from linkage to a nearby causal marker.
Variation at other genetic loci within the major histocompatibility complex (MHC) has been implicated in recent studies of susceptibility to rheumatoid arthritis and myocardial infarction, and variants within these loci have been shown to be functional in assays conducted in vitro and in vivo. [12] [13] [14] TNF is located within the class III region of the MHC in tandem with other genes encoding structurally related members of the TNF superfamily likely to modulate the role of TNF in inflammation and immunity. This gene-dense region exhibits extensive linkage disequilibrium (LD): 15 thus the association between TNFÀ308A and risk of trachomatous scarring might plausibly arise from high LD with a causal variant within or near one of these neighboring genes.
To test this hypothesis, we dissected the previously described association between this TNFÀ308 SNP and scarring trachoma in the Gambian population 4 in an extended, larger case-control study. Using information about the genetic architecture of the MHC Class III region spanning TNF in this population, 15 we analyzed the effects of SNPs and haplotypic constructs spanning TNF on the risk of scarring trachoma and trichiasis, and on the production of TNF in lymphocyte cultures stimulated with chlamydial antigen.
Results

Single-marker analysis
Single-marker conditional logistic regression (CLR) analysis showed that the IkBL-63 and LTA þ 252 SNPs were associated with risk of trichiasis, the most severe phenotype of trachoma (Tables 1 and 2 ). Both showed a trend of increasing risk of disease with increasing copy number ((OR ¼ 1.47, 95% CI ¼ 1.13, 1.91 (P for trend ¼ 0.004); and OR ¼ 1.37, 95% CI ¼ 1.06, 1.78 (P for trend ¼ 0.018) for IkBL-63T and LTA þ 252G, respectively)) ( Table 2 ). There was some evidence for a trend towards increasing risk of trichiasis with increasing number of TNFÀ308A alleles (OR ¼ 1.28, 95% CI ¼ 0.94, Table 2) . Multivariate CLR analysis of joint marker effects showed risk effects for IkBL-63T, LTA þ 252G and TNFÀ308A and a protective effect for LTA þ 77 T (data not shown). However, there is high pairwise LD between these markers in the Gambian population (Table 3) in particular IkBL-63T and LTA þ 259G are in almost complete LD (r 2 ¼ 0.964), and therefore separate effects of these markers on the risk of trichiasis cannot be distinguished.
Haplotype analysis
The haplotype analysis identified 11 haplotypes (only five of them at 41% population frequency) resolved by SNPs at nt À63 in the IkBL locus, þ 77 and þ 252 in the LTA locus and À308 and À238 in the TNF locus (Table 4) .
(HAP2) and IkBLÀ63T/ LTA þ 77G/LTA þ 252G/TNFÀ308A/TNFÀ238G (HAP3), both present at 420% population frequency, differing only at position TNFÀ308, were associated with risk of trichiasis independently from each other (CLR OR ¼ 1.61, 95% CI ¼ 1.16, 2.24, P ¼ 0.005 and OR ¼ 1.53, 95% CI ¼ 1.09, 2.15, P ¼ 0.015, respectively) and one IkBL-
(HAP 1) with protection (crude data in Table 4 ). Single haplotype CLR analysis showed an increasing risk of trichiasis with increasing number of copies of HAP2 (OR ¼ 1.45, 95% CI ¼ 1.06, 1.97, P ¼ 0.018), whereas the HAP1 haplotype was found to confer lower risk of trichiasis following a dose-response effect (CLR OR (95% CI) ¼ 0.75 (0.59, 0.95) P for trend ¼ 0.012) ( Tables 4 and  5a ). In multivariate CLR the effect of HAP2, but not of HAP3 on risk appeared partially confounded by the protective effect of HAP1 (Table 5b ). HAP1 and HAP2, which have opposite effects on risk, share the G allele at the TNF308 site. HAP2 and HAP3, which have statistically independent risk effects on trichiasis, share all the typed alleles except that HAP3 contains TNFÀ308A and HAP2 TNFÀ308G. This suggests that the SNP TNFÀ308A marker is a surrogate for some, but not all disease effects in the region.
The estimated ORs of the risk and protective haplotypes were very close to those defined by the SNP markers. The observed similarity between single marker and haplotype CLR estimates of the risks did not exclude the possibility of some of the captured effect(s) being inherent to these SNPs.
Genetic effects on TNF responses to chlamydial antigen
More TNF was produced in whole blood assays from case subjects with trachomatous scarring or trichiasis compared to controls when C. trachomatis serovar A elementary body (EB) was used as an activator of TNF production (Cases (n ¼ 26) TNF (pg/ml) mean ¼ 5562
We have previously shown that serovar A is the commonest serovar of C. trachomatis circulating in our study population, representing more than 90% of isolates. 16 We presume that the scarring sequelae in the cases resulted from cumulative exposure mainly to serovar A occurring over many years. There was no statistically significant difference in TNF production between cases and controls when Escherichia coli LPS was used (cases (TNF pg/ml) ¼ 1746 (95% CI 1380, 2112) and 3176 (95% CI 2808, 3544)) for 1 and 100 ng/ml LPS, respectively; controls (TNF pg/ml) 1576 (95% CI 1259, 1893) and 2502 (95% CI 2134, 2690) for 1 and 100 ng/ml LPS, respectively (F ¼ 0.46, 3.31 P ¼ 0.498 and 0.074 for 1 and 100 ng/ml of LPS). TNF production in the assays stimulated with chlamydial EB were analyzed according to their genotypes determined at each of the SNP sites studied and the inferred risk haplotypes containing them, that is, HAP1-3 (Tables 6 and 7 ). Both the risk TNFÀ308A allele and the HAP3 haplotype containing it were associated with increased TNF responses, independently of the clinical status of the study subjects (data not shown). The most striking increase in TNF production was observed among homozygotes for this risk allele/haplotype; both the TNF-308AA and HAP3/HAP3 genotypes correlated with the highest TNF responses. An analysis of subjects with only HAP3 or HAP2 suggested dose-dependent TNF responses: 3832, 4698 and 7194 pg/ml for HAP2/ HAP2 homozygotes, HAP3/HAP2 heterozygotes, and HAP3/HAP3 homozygotes respectively. HAP2 differs from HAP3 at the TNFÀ308 site, but is identical at the other typed marker sites.
Discussion
Our study found evidence that sequence variation within and close to the TNF locus was associated with risk of trachomatous trichiasis; and in some instances correlated with increased TNF responses induced by chlamydial EB. The study suggests that our previously reported association of an increased risk of scarring trachoma and trichiasis risk with the TNFÀ308A marker 4 in a smaller subset of the current data is part of a more complex picture.
TNF induction in whole blood by intact C. trachomatis EB may, or may not reflect events in natural infection. No effects were seen with TNF induction by E. coli LPS, which may have important structural differences with chlamydial LPS. 17 Heterogeneity according to cell type and stimulus has been described in the transcriptional regulation of TNF, [18] [19] [20] and the effect of putative regulatory polymorphism at the TNF locus may vary under different stimulatory conditions. Two risk haplotypes HAP2 and HAP3 spanning 25 kb across TNF and its adjacent loci were found to be independently associated with an increased risk of trichiasis. HAP3 is identical to HAP2 at all the typed marker sites except that it contains the TNF-308A allele, whereas HAP2 contains TNF-308G. We found, in a small subsample of subjects, that TNF responses to chlamydial activator were significantly greater among trichiasis cases than in pair-matched controls. Only HAP3, uniquely defined by TNFÀ308A, correlated with these TNF responses. This suggests that TNFÀ308A, which best defines the genetic risk captured by HAP3, may be either itself directly responsible or a good marker in LD with a functional SNP elsewhere within HAP3 for a high TNF producer phenotype associated with the pathogenesis of trichiasis.
The association between TNFÀ308A and risk of disease found in this study was weaker than in our earlier case-control study of scarring trachoma involving the TNFÀ308 marker. 4 Although the sample size and power of the current study are greater, its ethnic composition is different. Differences in allele frequencies and in LD at this and other loci exist between ethnic groups in the Gambia: [21] [22] [23] [24] accordingly ethnic variation in allele frequency and differences in LD between the TNFÀ308A allele and a putative causal allele or alleles within HAP3 may have produced a weaker association.
The presence of an independent risk haplotype HAP2, not associated with an increased in vitro TNF response may indicate that multiple mechanisms of genetic risk, involving or possibly not involving TNF may be operating. In support of this, the haplotype HAP1 was found to be associated with protection from trichiasis. From logistic regression analysis carried out to dissect this complex pattern of associations, the effects of haplotypes HAP1 and HAP3 on risk of trichiasis are statistically independent, whereas those of HAP1 and HAP2 show partial negative confounding by each other. Taken together, these findings suggest that trichiasis outcome may be influenced by at least two independent genetic determinants within or nearby the TNF gene, TNF SNPs linked to Ct sequelae and TNF production A Natividad et al perhaps operating in opposite directions. This phenomenon of multiple independent genetic effects arising in the TNF locus was observed previously in Gambian studies of severe malaria. 25, 26 Our study was not able to link this decreased risk of trichiasis with HAP1 to chlamydial TNF responses. Alternative molecular mechanisms may be important for the development of trichiasis.
There is evidence that both the risk-associated alleles IkBLÀ63T and LTA þ 77T may be functional. Together with its linked LTA þ 252G allele, IkBLÀ63T is the only allele exclusive to the risk haplotypes HAP3 and HAP2. This variant, which lies within a promoter/enhancer region of the IkBL gene has been associated with moderate transcriptional activity changes in vitro. 13 The nucleotide sequence surrounding the IkBLÀ63T risk allele is a putative binding site for the transcription factor dEF1, 12,27 a transcription repressor involved in Tcell development. IkBL is an IkBa-like gene presumably involved in the silencing of nuclear factor-kappa B (NF-kB) functionality 28 located some kilobases (kb) downstream the TNF locus. Three NF-kB consensus sequences within the TNF promoter have been observed to specifically bind to NF-kB in vitro, 20 suggesting a participation of NF-kB-signaling pathways in TNF gene regulation (reviewed in). 29 This raises the possibility that functional allelic variation in the IkBL gene affects TNFsignalling pathways. These data suggest a mechanism for pathogenesis wherein regulatory variants in the IkBL locus may contribute to variable pro-inflammatory and fibrotic TNF responsiveness in the conjunctival tissue of infected subjects, and hence influence chlamydial disease outcome. Accordingly, an association between variation in the promoter region of the IkBa gene on chromosome 14, close to sites of NF-kB transcription factor-DNA interaction and scarring trachoma has been reported. 30 The LTA þ 77T marker, associated with lower risk of trichiasis, uniquely defined the protective haplotype HAP1. The LTA þ 77 SNP has been reported to affect LTA protein production in human EBV-transformed B cells. 31 The functionality of the risk þ 77T allele is thought to reside in the fact that the activated B cell Factor-1 (ABF-1) only binds in the presence of this low producing þ 77T allele in vivo to suppress gene expression. 31 Conversely, the LTA þ 252G allele, present in HAP2 and HAP3 but absent in HAP1, has been linked to higher LTA transcription levels in vitro. 13, 14 Our data support the suggestion from in vitro functional studies of independent and opposite functional effects for LTA þ 77 T and þ 252G. 31 It is unclear how regulatory polymorphisms in the LTA gene directly mediate risk of trichiasis. LTA induces expression of vascular cell-adhesion molecule 1 (VCAM1) and intracellular cell-adhesion molecule 1 (ICAM1) along with that of TNF, IL1a and IL1b. 13 The coding polymorphism LTA þ 723 (Thr26Asn), which is in complete LD with LTA þ 252G in the Gambian population, has been linked to both high LTA expression and protein production. 13, 31 This SNP has been shown to increase the induction of several cell-adhesion molecules, including VCAM1. 13 In mice, genital infection with Chlamydia muridarum elicits expression of VCAM1 and ICAM1 on endothelial, stromal and epithelial cells within the genital mucosa 32, 33 and infiltrating T cells express an integrin profile supporting interaction with ICAM1 and VCAM1. If similar receptor-ligand interactions mediate T lymphocyte homing to the mucosa in human ocular chlamydial infection, genetically determined variation in host expression of adhesion molecules could contribute to the risk of sequelae following exposure.
This study found that risk alleles and haplotypes were more strongly, and in some cases exclusively, associated with risk of the trichiasis phenotype rather than with risk of milder forms of conjunctival scarring. This could be because the extreme phenotype of trichiasis is more suitable for genetic studies of risk as it is more easily and unambiguously observed. Alternatively, it could be that TNF specifically contributes to the progression of scarring to trichiasis. Both trichiasis and its recurrence after surgical correction have been associated with severe conjunctival inflammation. 34 TNF is highly expressed during episodes of conjunctival inflammation in these subjects with trichiasis (M Burton, personal communication) and may influence risk of disease progression in relation to the spectrum of TNF-inducible genes, such as matrix metalloprotease 9 that may be important in initiating fibrosis. 35, 36 We studied SNPs capturing common genetic variation within 25 kb of genome within the MHC region. The study suggests that host genetic variation at the TNF locus may affect risk of severe trachoma, but also that variation affecting related neighboring genes such as LTA, whose role in infectious, autoimmune and other disorders has started to be defined 13, [37] [38] [39] may be important. Uncovering functionally important SNPs, which directly influence risk of disease in this population will be complex, owing to the complicated nature of finescale LD in the MHC region in Gambians. 15 Further genotyping involving a denser set of genotypes across the region and a further increased sample size may be needed.
Subjects, materials and methods
Subjects
One thousand three hundred and fifteen subjects identified by clinical examination using WHO criteria 40 were recruited from trachoma endemic villages in the Gambia. They included 651 subjects with scarring trachoma (TS), of whom 307 additionally had Triquiasis (TT) pair-matched by sex, age, ethnic group and village of residence with unrelated subjects with normal eyelids. The subjects were otherwise healthy. Their mean age was 37 years (range 5-90) and 907 were women (69%). Ethnically 26% were Mandinka, 33% Wolof, 23% Jola and 11% Fula. The remaining 7% consisted of minority Gambian ethnic groups. We have reported previously disease associations at the IFNg, IL10 and MMP9 loci in these subjects. 41, 42 The study and its procedures were approved by the Gambia Government/MRC Ethics Committee (SCC 729/857), the Ethics committees of the London School of Hygiene and Tropical Medicine and of Oxford University, and are in accordance with the Declaration of Helsinki. Subjects diagnosed with trichiasis were offered free corrective surgery.
DNA extraction and SNP genotyping
Genomic DNA (gDNA) was isolated from either venous blood in EDTA or buccal brush samples. Genotypes were determined by the Sequenom system using matrix assisted laser desorption/ionization time-of-flight (MAL-DI-TOF) mass spectrometry as described previously. 41 Primer sequences are available on request.
SNP selection
The most informative haplotype-tagging SNPs (htSNPs) to type for disease association in Gambian subjects were identified by analyzing the pattern of LD in 128 Gambian chromosomes using 32 family trios not connected with this study. Full details are described elsewhere. 41 In brief, validated public SNPs of 45% minor allele frequency across the MHC class III genomic region encompassing TNF and its immediate neighbors IkBL and LTA loci were genotyped. After constructing haplotypes and applying the entropy maximization method, we identified a set of five htSNPs that described 90% of the observed haplotypic diversity (Figure 1 ) in this region. 15 Analytical methods LD estimates. The program HaploXT (http://archimedes.well.ox.ac.uk/gmap/pise/haploxt.html) was used to calculate pairwise LD estimates for the markers, expressed as the r 2 parameter (which is independent of the allele frequencies in the population). The input file for HaploXT was the haplotypes for each control subject generated by PHASE v1.1.
Haplotype reconstruction
The PHASE v1 program was used to infer haplotypes from population genotype data 43 and estimate the frequency of each inferred haplotype for cases and controls. To check the accuracy of haplotype reconstruction PHASE inferred haplotypes were compared with those from the SNPHAP program for haplotype construction from population data (http//www. hgmp.mrc.ac.uk/Menu/help/Snphap).
Association analysis
A crude, univariate and an adjusted analysis was first carried out by using Mantel-Haenszel (M-H) w 2 statistics (or Fisher's exact test if appropriate) to test for differences in minor allele and haplotype frequencies between cases of TS and of TT with their pair-matched unrelated controls. In addition CLR analysis for disease association taking into account matching of case-control pairs was performed. In the presentation of results, reference genotypes were generally selected to be those that were present at a highest frequency in our study population. Genotypes conferring susceptibility or protection are accordingly represented by odds ratios (OR) of greater than or less than one respectively. A test for trend in the odds ratios was carried out to check for a dose response effect relationship between genotype/ haplotype and disease allowing for potential confounders. All analysis was performed using STATA (v8.0) software.
Whole blood assays for TNF production Sixty subjects, 26 cases of TS (18 with additional TT) and 34 controls from the case-control study were recruited for functional studies. Whole blood collected in heparin tubes (Leo Pharmaceutical Products, Vilvoorde, Belgium) was diluted 1:10 with Rosewell Park Memorial Institute (RPMI) and incubated at 371C in a 5% CO 2 atmosphere with either C. trachomatis serovar A EBs (kindly provided by Dr Rosanna Peeling, 10 mg/ml final concentration) or E. coli LPS (Sigma, serotype 055:B5, 1 and 100 ng/ml final concentration) as activators. These activator concentrations were determined as those inducing maximal TNF production (data not shown). Tissue culture supernatants were collected after 24 h and their TNF concentration measured by capture enzyme-linked immunosorbent assay (ELISA) (Human TNF cytosets, Biosource Europe SA, Belgium) following the manufacturer's instructions. Briefly 96-well plates (Nunc-Immuno plate, MaxiSorp F96, Denmark) were coated with 1 mg/ml of anti-TNF antibodies (Clone 68B2B3, IgG1 and 68B6A3, IgG2), covered and incubated overnight at 41C. Standards (Recombinant Human TNF; 16 to 5000 pg/ml) were freshly reconstituted and diluted with R10 (RPMI, 10%FBS Sigma). Controls containing no activator were set up for each subject. Standards were tested in duplicate, and unknown and control samples were tested in triplicate. Aliquots of 100 ml of unknown, control or standards were added to the appropriate wells of the multi-well plate. Immediately 50 ml/well of 0.4 mg/ml of biotinylated anti-TNF antibodies were added and incubated for 2 h at room temperature. Bound antibodies were detected with streptavidin-POP (Boehringer Mannheim GmbH, Germany) and tetramethyl benzidine chromogen. The reaction was stopped with H 2 SO 4 . The optical density of each well was read at 450 nm on a DYNATECH MRX ELISA plate reader. The geometric mean OD values from each triplicate of controls and unknowns were calculated and a standard curve constructed by regression analysis to calculate the TNF concentration of each unknown sample. The Shapiro-Wilk test for normality was used to determine the appropriate statistical test: Kruskal-Wallis testing, Student's t-test and analysis of variance were used for subsequent analysis. Data were analyzed by using Stata V8.0. TNF SNPs linked to Ct sequelae and TNF production A Natividad et al
